0.3614
price down icon3.37%   -0.0126
after-market Dopo l'orario di chiusura: .36 -0.0014 -0.39%
loading

Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie

pulisher
Nov 18, 2024

Cyclacel Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Armistice Capital, LLC Increases Stake in Cyclacel Pharmaceutica - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

Cyclacel stock plunges to 52-week low of $0.37 amid market challenges - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals Raises $2.1M Through Warrant Exercise Deal at $0.415 Per Share | CYCC Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Cyclacel Pharmaceuticals appoints new auditor - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Cyclacel Faces Delisting Risk Despite 67% Lower Q3 Loss; Cash Concerns Mount | CYCC Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 09, 2024

(CYCCP) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 09, 2024
pulisher
Nov 08, 2024

A Data-Based Look At Cyclacel Pharmaceuticals Inc (CYCC) - Stocks Register

Nov 08, 2024
pulisher
Nov 04, 2024

Cyclacel stock plunges to 52-week low at $0.6 amid market challenges - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Cyclacel stock plunges to 52-week low at $0.74 amid market challenges - Investing.com India

Oct 28, 2024
pulisher
Oct 24, 2024

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - The Manila Times

Oct 24, 2024
pulisher
Oct 23, 2024

Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - ForexTV.com

Oct 23, 2024
pulisher
Oct 23, 2024

Nasopharyngeal Cancer Market Report: Growth Forecast and Key - openPR

Oct 23, 2024
pulisher
Oct 22, 2024

Sangamo Therapeutics, Cyclacel Pharma, GE Aerospace: 3 Stocks Retailers Are Most Bullish Tuesday Afternoon - Barchart

Oct 22, 2024
pulisher
Oct 21, 2024

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register

Oct 21, 2024
pulisher
Oct 13, 2024

CYCCPCyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock Latest Stock News & Market Updates - StockTitan

Oct 13, 2024
pulisher
Oct 12, 2024

Cyclacel Pharmaceuticals (CYCC) Price Target Increased by 11.56% to 13.94 - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Cyclacel stock plunges to 52-week low, touches $0.8 By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 09, 2024

Cyclacel stock plunges to 52-week low, touches $0.8 - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

CYCCCyclacel Pharmaceuticals, Inc Latest Stock News & Market Updates - StockTitan

Oct 09, 2024
pulisher
Oct 09, 2024

Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - The Manila Times

Oct 09, 2024
pulisher
Oct 01, 2024

Cyclacel stock plunges to 52-week low at $0.95 amid market challenges - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Cyclacel stock plunges to 52-week low at $0.95 amid market challenges By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Sep 25, 2024

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - ForexTV.com

Sep 25, 2024
pulisher
Sep 16, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

(CYCCP) Trading Report - Stock Traders Daily

Sep 16, 2024
pulisher
Sep 12, 2024

Cyclacel Pharmaceuticals (CYCC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Sep 12, 2024
pulisher
Sep 06, 2024

Cyclacel halts dividend on preferred stock - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

Cyclacel halts dividend on preferred stock By Investing.com - Investing.com Canada

Sep 06, 2024
pulisher
Sep 04, 2024

Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 03, 2024

Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - ForexTV.com

Sep 03, 2024
pulisher
Sep 03, 2024

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Benzinga

Sep 03, 2024
pulisher
Sep 02, 2024

Cyclacel Pharmaceuticals Inc (CYCC)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Sep 02, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):